Authors:
Dent, S
Zee, B
Dancey, J
Hanauske, A
Wanders, J
Eisenhauer, E
Citation: S. Dent et al., Application of a new multinomial phase II stopping rule using response andearly progression, J CL ONCOL, 19(3), 2001, pp. 785-791
Authors:
Shepherd, FA
Dancey, J
Arnold, A
Neville, A
Rusthoven, J
Johnson, RD
Fisher, B
Eisenhauer, E
Citation: Fa. Shepherd et al., Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma - A study of the National Cancer Institute of Canada Clinical Trials Group, CANCER, 92(3), 2001, pp. 595-600
Authors:
Angus, DJ
Hargreaves, M
Dancey, J
Febbraio, MA
Citation: Dj. Angus et al., Effect of carbohydrate or carbohydrate plus medium-chain triglyceride ingestion on cycling time trial performance, J APP PHYSL, 88(1), 2000, pp. 113-119
Authors:
Miller, WH
Reyno, LM
Loewen, GR
Huan, S
Winquist, E
Moore, M
Cato, A
Jaunakais, D
Truglia, JA
Matthews, S
Dancey, J
Eisenhauer, E
Citation: Wh. Miller et al., A phase I-II study of 9-cis retinoic acid and interferon-alpha 2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Trials Group study, ANN ONCOL, 11(11), 2000, pp. 1387-1389
Authors:
Shepherd, FA
Dancey, J
Ramlau, R
Mattson, K
Gralla, R
O'Rourke, M
Levitan, N
Gressot, L
Vincent, M
Burkes, R
Coughlin, S
Kim, Y
Berille, J
Citation: Fa. Shepherd et al., Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy, J CL ONCOL, 18(10), 2000, pp. 2095-2103
Authors:
Wong, F
Stewart, DE
Dancey, J
Meana, M
McAndrews, MP
Bunston, T
Cheung, AM
Citation: F. Wong et al., Men with prostate cancer: influence of psychological factors on informational needs and decision making, J PSYCHOSOM, 49(1), 2000, pp. 13-19
Authors:
Cripps, C
Burnell, M
Jolivet, J
Batist, G
Lofters, W
Dancey, J
Iglesias, J
Fisher, B
Eisenhauer, EA
Citation: C. Cripps et al., Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: An NCIC ClinicalTrials Group study, ANN ONCOL, 10(10), 1999, pp. 1175-1179
Authors:
Rusthoven, JJ
Eisenhauer, E
Butts, C
Gregg, R
Dancey, J
Fisher, B
Citation: Jj. Rusthoven et al., Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study, J CL ONCOL, 17(4), 1999, pp. 1194-1199